Richard Vandlen

13.2k citations
76 papers · 7.4k indexed · 3 hit papers · h-index 38
Topics
Monoclonal and Polyclonal Antibodies Research (22 papers)HER2/EGFR in Cancer Research (15 papers)Receptor Mechanisms and Signaling (9 papers)

In The Last Decade

Richard Vandlen

76 papers receiving 6.9k citations

Hit Papers

Identification of Heregulin, a Specific Activator of p185...1992202620032014199219941996250500750

Peers

Richard Vandlen
Comparison fields: 5 of 129
  • Molecular Biology 3.9k
  • Oncology 2.3k
  • Radiology, Nuclear Medicine and Imaging 1.8k
  • Immunology 881
  • Cellular and Molecular Neuroscience 832
Replace Christian Bruns with:
Christian Bruns Switzerland
Abraham M. de Vos United States
Mark Ultsch United States
Aviv Gazit Israel
G Carpenter United States
Michael F. Moran Canada
Adriana Haimovitz‐Friedman United States
Germaine Fuh United States
Frank R. Jirik Canada
Luis M. Montuenga Spain
Richard Vandlen relative to Christian Bruns Switzerland Christian Bruns's profile →
Citations per field
00.5×1.5×2.5×
Christian Bruns · 1×
Citations per year

Countries citing papers authored by Richard Vandlen

Since Specialization
Citations

This map shows the geographic impact of Richard Vandlen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Vandlen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Vandlen more than expected).

Fields of papers citing papers by Richard Vandlen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Vandlen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Vandlen. The network helps show where Richard Vandlen may publish in the future.

Co-authorship network of co-authors of Richard Vandlen

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Vandlen. A scholar is included among the top collaborators of Richard Vandlen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Vandlen. Richard Vandlen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 9
2 142
3 32
4 7
5 68
6 214
7 436
8 128
9 82
10 481
11 56
12 35
13 13
14
The Carboxyl-terminal Domain(111–165) of Vascular Endothelial Growth Factor Is Critical for Its Mitogenic Potencybreakdown →
507
15 17
16 19
17 60
18 27
19 48
20 10

About Richard Vandlen

Richard Vandlen is a scholar working on Occupational Therapy, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 76 papers that have together received 7.4k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (22 papers), HER2/EGFR in Cancer Research (15 papers) and Receptor Mechanisms and Signaling (9 papers). The work is most often cited by research in Oncology (2.3k citations), Radiology, Nuclear Medicine and Imaging (1.8k citations) and Immunology and Allergy (403 citations). Richard Vandlen has collaborated with scholars based in United States, France and Belgium. Frequent co-authors include Robert W. Akita, Mark X. Sliwkowski, Michael A. Raftery, Daniel G. Yansura, Helga Raab, Vincent Fitzpatrick, Richard A. Cerione, Kermit L. Carraway, Andrew Nuijens and James Lee. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026